0 false false false false false false false false false true false false false false false false No description of principal activity 2022-04-01 Sage Accounts Production Advanced 2021 - FRS102_2021 2,000 2,000 2,000 xbrli:pure xbrli:shares iso4217:GBP 10607649 2022-04-01 2023-03-31 10607649 2023-03-31 10607649 2021-04-01 2022-03-31 10607649 2022-03-31 10607649 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 10607649 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 10607649 bus:OrdinaryShareClass3 2022-04-01 2023-03-31 10607649 bus:Director1 2022-04-01 2023-03-31 10607649 bus:Director2 2022-04-01 2023-03-31 10607649 bus:Director3 2022-04-01 2023-03-31 10607649 core:WithinOneYear 2023-03-31 10607649 core:WithinOneYear 2022-03-31 10607649 core:ShareCapital 2023-03-31 10607649 core:ShareCapital 2022-03-31 10607649 core:RetainedEarningsAccumulatedLosses 2023-03-31 10607649 core:RetainedEarningsAccumulatedLosses 2022-03-31 10607649 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 10607649 core:Non-currentFinancialInstruments 2023-03-31 10607649 core:Non-currentFinancialInstruments 2022-03-31 10607649 bus:SmallEntities 2022-04-01 2023-03-31 10607649 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 10607649 bus:FullAccounts 2022-04-01 2023-03-31 10607649 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 10607649 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 10607649 bus:OrdinaryShareClass1 2023-03-31 10607649 bus:OrdinaryShareClass1 2022-03-31 10607649 bus:OrdinaryShareClass2 2023-03-31 10607649 bus:OrdinaryShareClass2 2022-03-31 10607649 bus:OrdinaryShareClass3 2023-03-31 10607649 bus:OrdinaryShareClass3 2022-03-31 10607649 bus:AllOrdinaryShares 2023-03-31 10607649 bus:AllOrdinaryShares 2022-03-31
COMPANY REGISTRATION NUMBER: 10607649
L&K HEALTH LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
31 March 2023
L&K HEALTH LIMITED
FINANCIAL STATEMENTS
YEAR ENDED 31 MARCH 2023
Contents
Pages
Balance sheet 1 to 2
Notes to the financial statements 3 to 4
L&K HEALTH LIMITED
BALANCE SHEET
31 March 2023
2023
2022
Note
£
£
Fixed assets
Investments
4
2,000
2,000
Current assets
Debtors
5
11,225
21,971
Cash at bank and in hand
36,524
59,819
------------
------------
47,749
81,790
Creditors: amounts falling due within one year
6
( 41,532)
( 73,573)
------------
------------
Net current assets
6,217
8,217
------------
------------
Total assets less current liabilities
8,217
10,217
------------
------------
Net assets
8,217
10,217
------------
------------
Capital and reserves
Called up share capital
7
3
3
Profit and loss account
8,214
10,214
------------
------------
Shareholders funds
8,217
10,217
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.
For the year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
L&K HEALTH LIMITED
BALANCE SHEET (continued)
31 March 2023
These financial statements were approved by the board of directors and authorised for issue on 28 November 2023 , and are signed on behalf of the board by:
Dr S Mani
Dr S Asalu
Director
Director
K C Isukapalli
Director
Company registration number: 10607649
L&K HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31 MARCH 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 35 Westgate, Huddersfield, HD1 1PA.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Investments
Investments are initially recorded at cost and are subject to an annual impairment review.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Investments
My Health Huddersfield Ltd
£
Cost
At 1 April 2022 and 31 March 2023
2,000
------------
Impairment
At 1 April 2022 and 31 March 2023
------------
Carrying amount
At 31 March 2023
2,000
------------
At 31 March 2022
2,000
------------
The company owns 1 ordinary A share of £2,000 each in My Health Huddersfield Limited.
The company is involved in the provision of services in the healthcare sector.
5. Debtors
2023
2022
£
£
Trade debtors
5,935
Other debtors
11,225
16,036
------------
------------
11,225
21,971
------------
------------
6. Creditors: amounts falling due within one year
2023
2022
£
£
Accruals and deferred income
28,535
62,576
Director loan accounts
12,997
10,997
------------
------------
41,532
73,573
------------
------------
7. Called up share capital
Issued, called up and fully paid
2023
2022
No.
£
No.
£
A Ordinary shares of £ 0.02 each
50
1
50
1
B Ordinary shares of £ 0.02 each
50
1
50
1
C Ordinary shares of £ 0.02 each
50
1
50
1
------------
------------
------------
------------
150
3
150
3
------------
------------
------------
------------
8. Control
There is no one controlling party of the company.
9. Related party transactions
The other debtors balance is owed by a partnership controlled by the directors. It is unsecured, repayable on demand and currently interest-free. The directors' loan balances are unsecured, repayable on demand and currently interest-free.